The race to the remedy: embracing our balance sheet, monthly

La course aux remèdes: place à notre bilan mensuel

As usual, The Newspaper has today published its monthly balance sheet of the state of the race to the remedy which is played everywhere on the planet, to defeat the COVID-19.

La course aux remèdes: place à notre bilan mensuel

Sébastien Ménard
Publisher and editor-in-chief of the Journal de Québec

More than four months after the beginning of the pandemic, it is the search for a vaccine that holds more of our attention this time, so that researchers from the University of Oxford in the United Kingdom, believe to be able to produce one in time for Christmas.

Drugs

At the same time, the search for drugs to relieve or control the symptoms of the COVID-19 progresses, it is also, great.

Our journalists make the point about the scientific advances the most promising and focus in particular on recent discoveries concerning the dextaméthasone, the remdésivir and colchicine, this drug which is at the heart of a global research conducted from Montreal.

La course aux remèdes: place à notre bilan mensuel

Richard Béliveau
A doctor in biochemistry

Coronavirus

Our columnist and has a doctorate in biochemistry Richard Béliveau adds new discoveries to the most significant, in a series of capsules that you can read at the end of the texts of our journalists.

The doc Béliveau has also focused his column to another aspect of the scientific research : it lifts the veil on the five targets of choice for the coronavirus, the experts begin to identify with more precision.

Good read !

Sébastien Ménard
Publisher and editor-in-chief of the Journal de Québec, project manager

 

A vaccine could be ready by the end of the year

The British could offer to the planet, this year, a Christmas gift priceless : an effective vaccine against the COVID-19.

Click here to view the article.

The 5 main targets of coronavirus

The coronavirus responsible for the COVID-19 is distinguished from the respiratory virus usual by his versatility which allows him to infect several different bodies and cause serious deficiencies that threaten the life of infected patients. At least five major targets of the virus have been identified so far.

Click here to see the chronicle of dr. Béliveau.

A first drug to reduce mortality

The dexamethasone lowers death in critically ill patients.

Click here to view the article.

The remdésivir on the verge of being approved by Health Canada

The agency should issue a notice of compliance for the use of the antiviral.

Click here to view the article.

Colchicine on track before the final sprint

The quebec researchers behind the study evaluating the effects of colchicine on the COVID-19 have good hope of obtaining positive results by the end of the summer so that a final blitz of recruiting patients into Africa, South America and the United States.

Click here to view the article.

Share Button